To meet the ever growing needs of modern medicine and combat emerging new diseases, there is a constant demand for improved diagnostic methods, therapeutic approaches and technologies. As a leading manufacturer of health care products, it is Abbott's goal to meet these needs worldwide. In Germany, Abbott has sites in Wiesbaden, Ludwigshafen, Wetzlar and Rangendingen.
Abbott Laboratories is a global, diversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company currently employs approximately 65,000 people and markets its products in more than 130 countries.
Abbott currently has nearly 4,100 employees working at the Wiesbaden, Ludwigshafen, Wetzlar and Rangendingen sites, and offers a wide range of pharmaceutical and diagnostic products – from prevention and diagnosis to treatment and cure. Thanks to substantial investments in discovery science, we have been able to develop innovative medications which lessen the threat of many diseases. Our pharmaceutical products help patients lead healthier and longer lives.
- Focus : Manufacturer
- Employees: 1001-5000
News about Abbott
08-Jul-2021 | Business
Francisco Partners to Acquire STARLIMS
Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses, announced that it has signed a definitive ...
20-Mar-2020 | Products
Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus
Abbott announced that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company's molecular test for novel ...
14-Sep-2018 | Market
Abbott Is Named Global Industry Leader in Sustainability for the Sixth Consecutive Year on the Dow Jones Sustainability Index (DJSI)
For the sixth consecutive year, Abbott has been named the leading company in its industry by the Dow Jones Sustainability Index (DJSI). Abbott is one of ...